Grove Biopharma
Laura Robinson, Ph.D., is the COO of Grove Biopharma. Dr. Robinson has 20 years of pharmaceutical industry experience, most recently as Group Director, Medical Affairs for AbbVie, with responsibilities spanning a variety of rare and specialty diseases in nephrology, endocrinology and neuroscience. During her career with AbbVie, Dr. Robinson also held senior leadership roles in marketing and global commercial development. Prior to joining the pharmaceutical industry, she was a consultant with McKinsey & Company, working in the biotech and semiconductor industries. Dr. Robinson holds a Ph.D. in inorganic chemistry from Northwestern University, where she was a National Science Foundation Fellow, conducting research on the photophysical properties of supported molybdenum clusters. She received her B.S. in Chemistry from the College of William and Mary in Virginia.
This person is not in any offices
Grove Biopharma
Grove is a seed-stage platform biotechnology company pioneering the discovery and development of an innovative class of biotherapeutics for challenging drug targets that address significant unmet medical needs.